About this trial
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.
Eligibility criteria
Qualifiers
Age 65 years and older
Disqualifiers
known haematological condition (myelodysplasia, leukemia, cancer)
inability to provide written informed consent
Trial design
Treatments tested in this trial
- Blood and bone marrow cell collection
Treatment groups
Sponsors and collaborators
Imelda Hospital, Bonheiden
Lead sponsor
Université Catholique de Louvain
Collaborator